173 related articles for article (PubMed ID: 31761032)
1. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
[TBL] [Abstract][Full Text] [Related]
2. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
3. Prognostic urinary miRNAs for the assessment of small renal masses.
Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
7. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
9. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
Waalkes S; Atschekzei F; Kramer MW; Hennenlotter J; Vetter G; Becker JU; Stenzl A; Merseburger AS; Schrader AJ; Kuczyk MA; Serth J
BMC Cancer; 2010 Sep; 10():503. PubMed ID: 20860816
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
12. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
Finelli A; Cheung DC; Al-Matar A; Evans AJ; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chin JL; Fleshner NE; Haider MA; Kachura JR; Sykes J; Jewett MAS
Eur Urol; 2020 Sep; 78(3):460-467. PubMed ID: 32680677
[TBL] [Abstract][Full Text] [Related]
13. The impact of gender and size on the pathology of small renal mass.
Hsieh PF; Chang CH; Huang CP; Chen CC; Chen KL; Chang SS; Yeh CC; Chen WC; Chou CL; Wu HC
Kaohsiung J Med Sci; 2012 Jul; 28(7):369-72. PubMed ID: 22726898
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of napsin A in renal neoplasms.
Zhu B; Rohan SM; Lin X
Diagn Pathol; 2015 Mar; 10():4. PubMed ID: 25889632
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive urine markers for the differentiation between RCCs and oncocytoma.
von Brandenstein M; Herden J; Köditz B; Huerta M; Nestler T; Heidenreich A; Fries JWU
J Clin Lab Anal; 2021 May; 35(5):e23762. PubMed ID: 33960011
[TBL] [Abstract][Full Text] [Related]
17. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
[TBL] [Abstract][Full Text] [Related]
18. Synchronous renal and adrenal masses: an analysis of 80 cases.
Bahrami A; Truong LD; Shen SS; Krishnan B
Ann Diagn Pathol; 2009 Feb; 13(1):9-15. PubMed ID: 19118776
[TBL] [Abstract][Full Text] [Related]
19. Value of urinary NMP-22 in patients with renal cell carcinoma.
Ozer G; Altinel M; Kocak B; Yazicioglu A; Gonenc F
Urology; 2002 Oct; 60(4):593-7. PubMed ID: 12385914
[TBL] [Abstract][Full Text] [Related]
20. Predictive model for recurrence of renal cell carcinoma by comparing pre- and postoperative urinary metabolite concentrations.
Morozumi K; Kawasaki Y; Maekawa M; Takasaki S; Sato T; Shimada S; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
Cancer Sci; 2022 Jan; 113(1):182-194. PubMed ID: 34710258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
